• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

11.35 -0.22 (-1.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
32 33 Next >
News headline image
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry ↗
June 02, 2022
In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its... 
Via Benzinga
News headline image
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
June 01, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 31, 2022 ↗
May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Continue To Decline ↗
May 29, 2022
Our index tracks 6 of the largest clinical-stage startups, which have an average market capitalization of $65.5M and an average stock price of $0.69/share. 
Via Talk Markets
News headline image
Compass Pathways: Q1 Earnings Insights ↗
May 10, 2022
Compass Pathways (NASDAQ:CMPS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 26, 2022 ↗
May 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34 
Via Benzinga
News headline image
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
May 25, 2022
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45 
Via Benzinga
News headline image
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company ↗
May 24, 2022
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 24, 2022 ↗
May 24, 2022
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61 
Via Benzinga
News headline image
Cybin, Small Pharma Among Top Psychedelic Movers Of Today ↗
May 23, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68 
Via Benzinga
News headline image
Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology ↗
May 23, 2022
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
News headline image
Can Psilocybin Help With Treatment-Resistant Depression? COMPASS Pathways Study Shows Promising Results ↗
May 23, 2022
COMPASS Pathways plc (NASDAQ: CMPS), a mental health care company, presented positive data from the randomized, controlled, double-blind study of psilocybin therapy, at the American Psychiatric... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 20, 2022 ↗
May 20, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77 
Via Benzinga
News headline image
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say ↗
May 20, 2022
Patents are the golden eggs of the booming psychedelic space. 
Via Benzinga
News headline image
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
May 19, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29 
Via Benzinga
News headline image
Cybin, Allied Among Top Psychedelic Movers Of Today ↗
May 18, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55 
Via Benzinga
News headline image
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
May 17, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32 
Via Benzinga
News headline image
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗
May 17, 2022
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 16, 2022 ↗
May 16, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Index Imploding ↗
May 14, 2022
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high. 
Via Talk Markets
News headline image
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
May 13, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 12, 2022 ↗
May 12, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06 
Via Benzinga
Compass Pathways Research Suggests Psilocybin Can Treat Anorexia
May 12, 2022
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From May 11, 2022 ↗
May 11, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS: 
Via Benzinga
News headline image
Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021 ↗
May 11, 2022
Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or... 
Via Benzinga
News headline image
Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗
May 10, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26 
Via Benzinga
News headline image
Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs ↗
May 10, 2022
Psychedelics policy action took center stage this week. 
Via Benzinga
News headline image
EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space ↗
May 10, 2022
The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 9, 2022 ↗
May 09, 2022
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34 
Via Benzinga
News headline image
A Preview Of Compass Pathways's Earnings ↗
May 09, 2022
Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Compass... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap